BTNL2
Basic information
Region (hg38): 6:32393339-32407181
Links
Phenotypes
GenCC
Source: 
ClinVar
This is a list of variants' phenotypes submitted to 
- not_specified (38 variants)
 - not_provided (8 variants)
 - BTNL2-related_condition (1 variants)
 
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the BTNL2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_001304561.2. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum | 
|---|---|---|---|---|---|---|
| synonymous | 2 | |||||
| missense | 36 | 42 | ||||
| nonsense | 1 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 37 | 3 | 5 | 
GnomAD
Source: 
| Gene | Type | Bio Type | Transcript | Coding Exons | Length | 
|---|---|---|---|---|---|
| BTNL2 | protein_coding | protein_coding | ENST00000454136 | 7 | 13166 | 
| pLI Probability LOF Intolerant  | pRec Probability LOF Recessive  | Individuals with no LOFs  | Individuals with Homozygous LOFs  | Individuals with Heterozygous LOFs  | Defined | p | 
|---|---|---|---|---|---|---|
| 8.56e-11 | 0.150 | 100966 | 1860 | 22922 | 125748 | 0.104 | 
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 1.50 | 194 | 263 | 0.739 | 0.0000135 | 3104 | 
| Missense in Polyphen | 59 | 85.132 | 0.69304 | 1087 | ||
| Synonymous | 0.885 | 98 | 110 | 0.893 | 0.00000648 | 950 | 
| Loss of Function | 0.546 | 17 | 19.6 | 0.867 | 8.40e-7 | 231 | 
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p | 
|---|---|---|
| African & African-American | 0.356 | 0.341 | 
| Ashkenazi Jewish | 0.0334 | 0.0327 | 
| East Asian | 0.194 | 0.186 | 
| Finnish | 0.165 | 0.157 | 
| European (Non-Finnish) | 0.0707 | 0.0663 | 
| Middle Eastern | 0.194 | 0.186 | 
| South Asian | 0.0853 | 0.0814 | 
| Other | 0.101 | 0.0967 | 
dbNSFP
Source: 
- Function
 - FUNCTION: Negative regulator of T-cell proliferation. {ECO:0000250}.;
 - Disease
 - DISEASE: Sarcoidosis 2 (SS2) [MIM:612387]: An idiopathic, systemic, inflammatory disease characterized by the formation of immune granulomas in involved organs. Granulomas predominantly invade the lungs and the lymphatic system, but also skin, liver, spleen, eyes and other organs may be involved. {ECO:0000269|PubMed:15735647}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. A nucleotide transition affecting a splice donor site results in the use of an alternative splice site and the production of isoform 3. Individuals expressing isoform 3 have a higher risk for sarcoidosis.;
 - Pathway
 - Butyrophilin (BTN) family interactions;Immune System;Adaptive Immune System 
(Consensus)  
Haploinsufficiency Scores
- pHI
 - 0.0567
 - hipred
 - N
 - hipred_score
 - 0.153
 - ghis
 - 0.394
 
Essentials
- essential_gene_CRISPR
 - essential_gene_CRISPR2
 - N
 - essential_gene_gene_trap
 - gene_indispensability_pred
 - N
 - gene_indispensability_score
 - 0.0448
 
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | High | High | High | 
| Primary Immunodeficiency | High | High | High | 
| Cancer | High | High | High | 
Mouse Genome Informatics
- Gene name
 - Btnl2
 - Phenotype
 
Gene ontology
- Biological process
 - regulation of immune response;T cell receptor signaling pathway
 - Cellular component
 - plasma membrane;external side of plasma membrane;integral component of membrane
 - Molecular function
 - signaling receptor binding